341 related articles for article (PubMed ID: 25696896)
1. Smoothing the crescent curve: sickle cell disease.
Talano JA; Cairo MS
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):468-74. PubMed ID: 25696896
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
Talano JA; Cairo MS
Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'.
Freed J; Talano J; Small T; Ricci A; Cairo MS
Bone Marrow Transplant; 2012 Dec; 47(12):1489-98. PubMed ID: 22179556
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
Tanhehco YC; Bhatia M
Curr Opin Hematol; 2019 Nov; 26(6):448-452. PubMed ID: 31483336
[TBL] [Abstract][Full Text] [Related]
5. Curative treatment for severe sickle cell disease: allogeneic transplantation.
Oshrine B; Talano JA
Clin Adv Hematol Oncol; 2015 Apr; 13(4):249-56. PubMed ID: 26352583
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease.
Gluckman E
Hematology Am Soc Hematol Educ Program; 2013; 2013():370-6. PubMed ID: 24319206
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.
Kassim AA; Sharma D
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):259-266. PubMed ID: 28641096
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic cellular gene therapy for hemoglobinopathies.
Gaziev J; Lucarelli G
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
[TBL] [Abstract][Full Text] [Related]
9. When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease.
Joseph JJ; Abraham AA; Fitzhugh CD
Semin Hematol; 2018 Apr; 55(2):94-101. PubMed ID: 29958565
[TBL] [Abstract][Full Text] [Related]
10. Allogenic hematopoietic stem cell transplantation in sickle cell disease.
Furstenau DK; Tisdale JF
Transfus Apher Sci; 2021 Feb; 60(1):103057. PubMed ID: 33485798
[TBL] [Abstract][Full Text] [Related]
11. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease.
Strocchio L; Zecca M; Comoli P; Mina T; Giorgiani G; Giraldi E; Vinti L; Merli P; Regazzi M; Locatelli F
Br J Haematol; 2015 Jun; 169(5):726-36. PubMed ID: 25818248
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.
Locatelli F; Pagliara D
Pediatr Blood Cancer; 2012 Aug; 59(2):372-6. PubMed ID: 22544533
[TBL] [Abstract][Full Text] [Related]
13. Will developments in allogeneic transplantation influence treatment of adult patients with sickle cell disease?
Chakrabarti S; Bareford D
Biol Blood Marrow Transplant; 2004 Jan; 10(1):23-31. PubMed ID: 14752776
[TBL] [Abstract][Full Text] [Related]
14. Blood and marrow transplantation for sickle cell disease: overcoming barriers to success.
Bolaños-Meade J; Brodsky RA
Curr Opin Oncol; 2009 Mar; 21(2):158-61. PubMed ID: 19532018
[TBL] [Abstract][Full Text] [Related]
15. Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.
Arnold SD; Bhatia M; Horan J; Krishnamurti L
Br J Haematol; 2016 Aug; 174(4):515-25. PubMed ID: 27255787
[TBL] [Abstract][Full Text] [Related]
16. Advances in allogeneic stem cell transplantation for hemoglobinopathies.
Al Jefri AH
Hemoglobin; 2011; 35(5-6):469-75. PubMed ID: 21967642
[TBL] [Abstract][Full Text] [Related]
17. Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
Leonard A; Tisdale J; Abraham A
Br J Haematol; 2020 May; 189(3):408-423. PubMed ID: 32034776
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease.
Inam Z; Tisdale JF; Leonard A
Expert Rev Hematol; 2023; 16(11):879-903. PubMed ID: 37800996
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease.
Justus D; Perez-Albuerne E; Dioguardi J; Jacobsohn D; Abraham A
Pediatr Blood Cancer; 2015 Jul; 62(7):1285-7. PubMed ID: 25663074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
